Asfotase Alfa
Records for this ingredient, by country (identity only).
ATC A16AB13 · 10 markets · 35 records
AU 6 records · 2 shown of 2
- 100 mg/mL per mL / per unit basis not statedinjectionSTRENSIQ asfotase alfa rch 80 mg/0.80 mL injection solution vial
- 40 mg/mL per mL / per unit basis not statedinjectionSTRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 5 records · 2 shown of 2
JP 5 records · 5 shown of 5
- 40 mg/1 mLinjectionストレンジック皮下注80mg/0.8mL
- 80 mg/0.8 mLinjectionストレンジック皮下注80mg/0.8mL
- 28 mg/0.7 mLinjectionストレンジック皮下注80mg/0.8mL
- 18 mg/0.45 mLinjectionストレンジック皮下注80mg/0.8mL
- 12 mg/0.3 mLinjectionストレンジック皮下注80mg/0.8mL
US 4 records · 4 shown of 4
GB 4 records · 4 shown of 4
- 40 mg/1 mLinjectionStrensiq 18mg/0.45ml solution for injection vials
- 80 mg/0.8 mLinjectionStrensiq 18mg/0.45ml solution for injection vials
- 28 mg/0.7 mLinjectionStrensiq 18mg/0.45ml solution for injection vials
- 18 mg/0.45 mLinjectionStrensiq 18mg/0.45ml solution for injection vials
HK 4 records · 0 shown of 0
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
SG 2 records · 2 shown of 2
- 100 mg/mL per mL / per unit basis not statedinjectionSTRENSIQ SOLUTION FOR INJECTION 40 MG/ML
- 40 mg/mL per mL / per unit basis not statedinjectionSTRENSIQ SOLUTION FOR INJECTION 40 MG/ML
TW 2 records · 2 shown of 2
- 100 mg per mL / per unit basis not statedinjectionSTRENSIQ 40 mg/ml solution for subcutaneous賜壯骼皮下注射劑100毫克/毫升
- 40 mg per mL / per unit basis not statedinjectionSTRENSIQ 40 mg/ml solution for subcutaneous賜壯骼皮下注射劑40毫克/毫升
FR 2 records · 2 shown of 2
- 40 mg/1 mLinjectionSTRENSIQ 100 mg/ml, solution injectable
- 100 mg/1 mLinjectionSTRENSIQ 100 mg/ml, solution injectable
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 40 mg/1 mL injection | Strensiq 18mg/0.45ml solution for injection vials | ストレンジック皮下注80mg/0.8mL | STRENSIQ 100 mg/ml, solution injectable | |||||||
| 40 mg per mL / per unit basis not stated cannot compare liquid | STRENSIQ | STRENSIQ | ||||||||
| 100 mg per mL / per unit basis not stated cannot compare injection | STRENSIQ 40 mg/ml solution for subcutaneous 賜壯骼皮下注射劑100毫克/毫升 | |||||||||
| 100 mg/mL per mL / per unit basis not stated cannot compare injection | STRENSIQ asfotase alfa rch 80 mg/0.80 mL injection solution vial | STRENSIQ SOLUTION FOR INJECTION 40 MG/ML | ||||||||
| 80 mg/0.8 mL injection | Strensiq 18mg/0.45ml solution for injection vials | ストレンジック皮下注80mg/0.8mL | ||||||||
| 40 mg per mL / per unit basis not stated cannot compare injection | STRENSIQ 40 mg/ml solution for subcutaneous 賜壯骼皮下注射劑40毫克/毫升 | |||||||||
| 40 mg/mL per mL / per unit basis not stated cannot compare injection | STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial | STRENSIQ SOLUTION FOR INJECTION 40 MG/ML | ||||||||
| 28 mg/0.7 mL injection | Strensiq 18mg/0.45ml solution for injection vials | ストレンジック皮下注80mg/0.8mL | ||||||||
| 18 mg/0.45 mL injection | Strensiq 18mg/0.45ml solution for injection vials | ストレンジック皮下注80mg/0.8mL | ||||||||
| 100 mg per mL / per unit basis not stated cannot compare liquid | STRENSIQ | |||||||||
| 80 mg/0.8 mL liquid | STRENSIQ | |||||||||
| 28 mg/0.7 mL liquid | STRENSIQ | |||||||||
| 18 mg/0.45 mL liquid | STRENSIQ | |||||||||
| 100 mg/1 mL injection | STRENSIQ 100 mg/ml, solution injectable | |||||||||
| 12 mg/0.3 mL injection | ストレンジック皮下注80mg/0.8mL | |||||||||
unknown | STRENSIQ | STRENSIQ SOLUTION FOR INJECTION 18MG/0.45ML | STRENSIQ |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
7 more strength/form rows are recorded only in CA · AU · SG · TW · HK · EU · FR and are not shown in this table. Hay 7 filas de concentración/forma registradas solo en CA · AU · SG · TW · HK · EU · FR que no se muestran en esta tabla. 另有 7 个规格/剂型仅在 CA · AU · SG · TW · HK · EU · FR 有记录（未在本表显示）。 另有 7 個規格/劑型僅在 CA · AU · SG · TW · HK · EU · FR 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.